Mammography is the standard of care for breast screening but, for women with dense breasts, mammography can miss as many as half of all cancers.

Adding a supplemental whole breast exam, to the mammogram, can find most of those missed cancers.

If Cancer is found, it is better to:

 

SonoCiné Patient Testimonial

SonoCiné is an automated breast ultrasound system that has been cleared by FDA as an adjunctive examination to mammography. It is a complimentary examination and not a replacement for mammography.


Peer reviewed, published, clinical trials demonstrated that SonoCiné, when used as an adjunct to mammography, found more and smaller cancers than were found by mammography alone.

SonoCiné Multi-Center Clinical Study
SonoCiné Reader’s Study
 

 

 

 

Fatty Tissue

Dense Tissue

SonoCiné Exam

Click here to play the SonoCiné Study

EASY-TO-READ MAMMOGRAM

HARD-TO-READ MAMMOGRAM

SUPPLEMENTAL ULTRASOUND FINDS CANCERS IN HARD-TO-READ MAMMOGRAMS

Cancer (white spot) is easily seen in the dark background of the fatty-breast mammogram

Cancer (white spot) is difficult to see in the white background of the dense breast

A cancer in a dense breast is easily seen in a SonoCiné ultrasound examination

~60% OF ALL WOMEN

~40% OF ALL WOMEN

 

 

  

 

SonoCiné’s clinical trials demonstrated that, as an adjunctive examination, it found more and smaller cancers than mammography without incurring excessive false positive or biopsies

More than 6,400 exams compared mammography and SonoCiné as screening modalities in dense-breasted patients.

Mammography performed as expected (3.6 cancers discovered per 1,000 patients)

SonoCiné found more and smaller cancers than mammography in dense-breasted patients in this study.

  • 3.6 additional, or mammographically-occult, cancers per 1,000 patients.
  • Median size of mammographically-occult cancers was 9mm.

PPV of SonoCiné-inspired biopsies was 38%.

 

  
 

No compression, No radiation, No needles.
A compliment to your Mammogram, not a replacement.